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SUMMARY
Postnatal mammary gland development and differentiation occur during puberty and pregnancy. To explore the role of DNA methyl-
ation in these processes, we determined the genome-wide DNA methylation and gene expression profiles of CD24+CD61+CD29hi,
CD24+CD61+CD29lo, and CD24+CD61CD29lo cell populations that were previously associated with distinct biological properties at
different ages and reproductive stages. We found that pregnancy had the most significant effects on CD24+CD61+CD29hi and
CD24+CD61+CD29lo cells, inducing distinct epigenetic states that were maintained through life. Integrated analysis of gene expression,
DNA methylation, and histone modification profiles revealed cell-type- and reproductive-stage-specific changes. We identified p27 and
TGFb signaling as key regulators of CD24+CD61+CD29lo cell proliferation, based on their expression patterns and results frommammary
gland explant cultures. Our results suggest that relatively minor changes in DNA methylation occur during luminal differentiation
compared with the effects of pregnancy on CD24+CD61+CD29hi and CD24+CD61+CD29lo cells.
INTRODUCTION
The mammary gland is a unique organ because its func-
tional development and differentiation are completed
postnatally. Ductal branching and elongation take place
during puberty, whereas lobulo-alveolar development and
differentiation intomilk-secreting alveoli occur duringpreg-
nancy and lactation (Hennighausen and Robinson, 2005).
The mammary ducts are composed of the outer contractile
myoepithelial cells and the inner luminal epithelial cells.
These two main epithelial lineages originate from bipo-
tential mammary epithelial stem cells (MaSCs) during em-
bryonic development, and in postnatal life they may be
maintained by lineage-committed progenitors, with bipo-
tential stem cells playing a lesser role under physiologic
conditions (Rios et al., 2014; Shackleton et al., 2006; Spike
et al., 2012; Van Keymeulen et al., 2011). In vivo lineage
tracing andmammary transplant studies regarding the rela-
tive role of bipotential stem cells and committed progeni-
tors in the maintenance of adult mammary glands have
been controversial (Prater et al., 2014; Rios et al., 2014;
Shackleton et al., 2006; Van Keymeulen et al., 2011), likely
due to the different experimental conditions used and the
relative plasticity of mammary epithelial progenitors (van
Amerongen et al., 2012). The cell-surface markers CD24,
CD29, and CD61 have been identified in multiple strains
of mice as markers of three distinct mammary epithelial
populations enriched for MaSCs, but they also contain my-
oepithelial and other basal cells (CD24+CD61+CD29hi),
luminal progenitors (CD24+CD61+CD29lo), and mature lu-
minal epithelial cells (CD24+CD61CD29lo) (Asselin-Labat
et al., 2007; Desgrosellier et al., 2014; Gu et al., 2013;
Shackleton et al., 2006). CD24+CD61+CD29hi cells can
give rise to both myoepithelial and luminal lineages in
mammary transplant assays, whereas CD24+CD61+CD29lo
cells can only produce mature luminal cells (Asselin-Labat
et al., 2007; Prater et al., 2014).
Cellular differentiation is governed by epigenetic pro-
grams such as DNA methylation and chromatin modifica-
tion (Smith and Meissner, 2013). The requirement for
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DNA methylation in early embryonic development has
been demonstrated by the phenotype of DNAmethyltrans-
ferase (DNMT) knockout mouse models in which homozy-
gous deletion of Dnmt1, Dnmt3a, or Dnmt3b leads to early
embryonic or postnatal lethality (Smith and Meissner,
2013). DNMTs are also required for embryonic stem cell
(ESC) differentiation (Smith and Meissner, 2013). Changes
in DNAmethylation and histonemodification patterns are
clearly associated with the differentiation of normal adult
tissue-specific stem cells (Smith and Meissner, 2013), but
their relevance for cell-type-specific expression patterns
has not been investigated.
Here, we describe the comprehensive molecular
profiling of three distinct mammary epithelial cell
types (CD24+CD61+CD29hi, CD24+CD61+CD29lo, and
CD24+CD61CD29lo) from C57BL6 female mice of
different ages and reproductive stages. We also analyzed
the effects of DNMT inhibitors and genetic depletion of
Dnmt1 by analyzing mammary glands from 5-azacytidine
(AzaC)-treated andDnmt1+/chip hypomorphicmice (Gaudet
et al., 2003), respectively.
RESULTS
Differences in Mammary Gland Morphology and
Cellular Composition Related to Age, Reproductive
Stage, and DNMTActivity
To establish the normal mammary epithelial states at
different ages and reproductive stages, we first examined
the mammary gland morphology and the relative frac-
tion of three distinct cell populations defined by fluores-
cence-activated cell sorting (FACS) in pre- and postpubertal
and old virgin (3, 9, and 24 weeks old, respectively), early
and late pregnant (day 10 [D10], D16, andD19), and retired
breeder (28–36 weeks old, R5 pregnancies/mouse) C57/
BL6 femalemice (Figures 1A–1C; Table S1 available online).
Despite the fact that themammary gland remodels to a vir-
gin-like state after pregnancy, the mammary glands of
retired breeders had more tertiary branching compared
with 9-week-old virgins, and the mammary glands of 24-
week-old virgins were morphologically the most similar
to the 9-week-old virgin glands (Figure 1A).
The relative frequencies of CD24+CD61+CD29hi,
CD24+CD61+CD29lo, and CD24+CD61CD29lo cells
were determined by FACS (Desgrosellier et al., 2014; Gu
et al., 2013). Similar to previous findings (Desgrosellier
et al., 2014), the most significant differences were
observed in the relative fraction of CD24+CD61+CD29lo
cells, with a gradual decline in 3–9- to 24-week-old vir-
gins. The lowest levels were found in pregnant mice, fol-
lowed by a return to 9-week-old virgin levels in retired
breeders (Figures 1B and 1C). However, due to the larger
absolute number of mammary epithelial cells in pregnant
mice, this relative decline during pregnancy may not
reflect a decrease in the absolute numbers of these cells.
The relative frequency of CD24+CD61CD29lo cells gradu-
ally increased during pregnancy and returned to prepu-
berty levels in retired breeders. Interestingly, the effects
of aging on the frequency of CD24+CD61+CD29hi and
CD24+CD61+CD29lo cells were similar to those of preg-
nancy, since the 24-week-old virgin values were in be-
tween the 9-week-old virgin and D10 pregnant levels
(Figure 1C).
Next, we investigated the role of DNMT activity in
ductal development (virgin mice) and in alveogenesis
(pregnant mice) by using azacitidine (AzaC) DNMT inhib-
itor (Figure S1A). We also tested the effects of valproic acid
(VPA), a histone deacetylase (HDAC) inhibitor, since it
has been shown to promote cellular differentiation in
other systems (Tou et al., 2004). The efficacy of AzaC
treatment was confirmed by analysis of DNA methylation
of SINE B1 elements (Kramerov and Vassetzky, 2005) and
the expression of genes silenced by DNA methylation
(Figures S1B and S1C). We found that the overall size
and extent of ductal/alveolar structures decreased sig-
nificantly in AzaC-treated mice compared with control
mice, whereas no differences were seen in VPA-treated
animals (Figures 1D and 1E). The relative fractions of
CD24+CD61+CD29hi and CD24+CD61+CD29lo did not
change significantly upon either AzaC or VPA treatment
in virgin mice (Figure 1F). In contrast, there was a small
but significant decrease of CD24+CD61+CD29hi cells in
VPA-treated pregnant animals, and both drugs induced
a slight but significant increase in the representation of
CD24+CD61CD29lo cells in both virgin and pregnant
mice. Thus, the observed morphologic changes in AzaC-
treated animals were more likely due to decreased cell
proliferation and an overall decrease in mammary epithe-
lial cells rather than to specific effects on any cell type
(Figure 1F).
Since AzaC treatment may have indirect effects, we
analyzed the mammary gland morphology and cellular
composition in Dnmt1+/chip (heterozygous Dnmt1 hypo-
morph) mice to directly address the role of Dnmt1
and DNA methylation in mammary gland development
(Figures 1G and 1H). In this mouse model, an 55%
decrease of Dnmt1 expression was associated with a
slight increase in the relative representation of CD24+
CD61+CD29hi cells and a slight decrease of CD24+CD61+
CD29lo cells compared with wild-type (WT)/WT 9-week-
old virgin mice, but neither change was significant. Un-
fortunately, we were not able to characterize Dnmt1+/chip
mice during pregnancy, where the changes might be
more pronounced, due to difficulties with breeding these
animals.
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Cell-type and Reproductive-Stage-Specific Gene
Expression Patterns
To define molecular differences among the three cell
types at different ages and reproductive stages, we analyzed
the gene expression profiles of each cell population from
multiple independent mice (pools of cells from
36–108 mice depending on the developmental stage).
This analysis revealed significant cell-type-, age-, and
Figure 1. Changes in the Mammary Epithelium Associated with Age, Reproductive Stage, and AzaC Treatment
(A) Morphology of mouse mammary glands at different age and reproductive stages by whole-mount (top; scale bar, 2.5 mm), H&E (middle;
scale bar, 50 mm), and smooth muscle actin (SMA, bottom; scale bar, 50 mm) staining.
(B and C) Representative FACS profiles (B) and graph (C) depicting the relative frequencies of the indicated cell populations at the
specified age and reproductive stages. Asterisks indicate significant differences (*p < 0.05, **p < 0.005, ***p < 0.001, ****p < 0.0001;
two-way ANOVA, Tukey’s multiple-comparison test). Error bars represent median ± SEM.
(D) Morphologic changes induced by AzaC and VPA treatment based on whole-mount (top; scale bar, 2.5 mm), H&E (middle; scale bar,
50 mm), and SMA (bottom; scale bar 50 mm) staining.
(E) AzaC-treatment-induced changes in mammary gland size and ductal branching (assessed by the number of cross-sectional ducts) in
pregnant and virgin mice, respectively. Inset shows representative mammary glands from control and AzaC-treated pregnant mice.
(F) Relative fraction of CD61+CD29hi, CD24+CD61+CD29lo, and CD24+CD61CD29lo cells in AzaC- or VPA-treated mice. Asterisks indicate
significant differences (*p < 0.05, **p < 0.005, ***p < 0.001, ****p < 0.0001; two-way ANOVA, Dunnett’s multiple-comparison test)
between PBS control and AzaC- or VPA-treated groups within each cell type. Error bars represent median ± SEM.
(G) Whole mounts of mouse mammary glands from Dnmt1+/chip mice. Scale bar, 2.5 mm.
(H) Relative fraction of CD61+CD29hi, CD24+CD61+CD29lo, and CD24+CD61CD29lo cells in 9-week-old virgin Dnmt1+/chip mice. Error bars
represent median ± SEM.
See also Figure S1 and Table S1.
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reproductive-stage-specific differences, with the clearest
separation of CD24+CD61+CD29hi cells from the other
two cell types, and pregnant samples from all others (Fig-
ures 2A and 2B). Age and reproductive stage had the most
pronounced effects on the profiles of CD24+CD61+CD29hi
andCD24+CD61+CD29lo cells (Figure 2B; Tables S2 and S3),
correlating with our data in humans (Choudhury et al.,
2013). Several genes involved in growth factor signaling
(e.g., Igf2r) were highly expressed in CD24+CD61+CD29lo
cells of 3- to 9-week-old virginmice but decreased in old vir-
gin, pregnant, and retired breeders. In contrast, genes
related to milk production (e.g., Csna) and lactation (e.g.,
Oxtr) were highly expressed in CD24+CD61+CD29lo and
CD24+CD61CD29lo cells of pregnant mice.
Next, we analyzed the relative differences in gene expres-
sion between cell types at different stages and stage-specific
differences within the same cell type (Table S4). These ana-
lyses provided evidence of luminal differentiation and
highlighted the distinct transcriptional state during preg-
nancy (Figure 2C). Although CD24+CD61+CD29lo and
CD24+CD61CD29lo cells had correlated transcription in
virgin and retired breeder mice, a decrease in correlation
during pregnancy showed the activation of unique expres-
sion programs. Further analysis of genes with the most sig-
nificant differences according to cell type and develop-
mental stage revealed enrichment in distinct biological
functions. Development-related genes were specific to
and highly expressed in CD24+CD61+CD29hi and
CD24+CD61+CD29lo cells in all stages (Figures 2D and 2E;
Tables S2 and S3). In young virgin mice, CD24+CD61
CD29lo cells displayed a significant overlap with
CD24+CD61+CD29lo cells, thus implying that full luminal
maturation may not occur until after pregnancy. In preg-
nant mice, lactation was a top functional category in
CD24+CD61CD29lo cells, correlating with lactation-asso-
ciated changes during pregnancy. Some pathways were
significantly enriched in multiple pairwise comparisons
(Figure S2A). For example, neuroactive ligand-receptor in-
teractions were highly represented in changes observed
in both CD24+CD61+CD29hi and CD24+CD61+CD29lo
cells due to age and reproductive stage, although the actual
genes varied (Table S5).
Because transcription factors (TFs) are key regulators of
cellular phenotypes, we investigated their expression pat-
terns in more detail. We found that the expression of
many TFs known to be required for mammary gland devel-
opment and differentiation was restricted to a specific cell
type and developmental stage. For example, Elf5 and
Stat5, which have known roles in alveolar differentiation
and lactation, were most highly expressed in CD24+CD61+
CD29lo and CD24+CD61CD29lo cells of pregnant mice,
whereas Foxa1 and Esr1 luminal genes had the highest
expression in CD24+CD61+CD29lo cells of young virgin
mice (Figures 2F and S2B). CD24+CD61+CD29hi cells had
the highest number of unique TFs, including several mem-
bers of the Id, Snai, and Foxo families (Figures 2G–2I). Id4
and Snai2 were specifically expressed in CD24+CD61+
CD29hi cells regardless of age and reproductive stage
(Figure 2G), whereas Snai1 was relatively specific to
CD24+CD61+CD29hi and CD24+CD61+CD29lo cells from
young virgin mice, and Foxd3 and Foxa3 were relatively
specific to those from pregnant and retired breeder mice
(Figure 2H). Snai1 can cooperatewith Sox9 to induceMaSCs
(Guo et al., 2012). Foxd3 is essential for ESCs and for main-
taining pluripotent cells during embryonic development
(Hanna et al., 2002). Thus, the high expression of these
TFs in the CD24+CD61+CD29hi cell fraction is consistent
with a functional role in stem cells.
Cell-Type-Specific and Pregnancy-Induced Changes in
DNA Methylation Patterns
Next, we analyzed the global DNA methylation profiles of
each cell type at all ages and reproductive stages using
reduced representation bisulfite sequencing (RRBS) (Boyle
et al., 2012). The global methylation signature of these
mammary epithelial cell populations is more closely
related to that of skin than to that of blood (Bock et al.,
2012; Figure 3A), which is in agreement with its develop-
mental origin. In contrast to the relatively large difference
among blood, skin, and mammary samples based on Pear-
son correlation, the DNA methylation profiles of the
mammary epithelial cell types were relatively similar.
Nonetheless, global (Figure S2C) as well as promoter and
enhancer DNA methylation signatures (Figures 3B and
3C) varied more between cellular states than between
reproductive states. However, contrary to the clustering
of samples based on expression data in which all
CD24+CD61+CD29hi cells cluster together, the DNA
methylation data highlighted a unique cluster that
contained only the CD24+CD61+CD29hi cells from old
virgin, pregnant, and retired breeder mice (Figures 3B
and 3C). These results suggest that aging and pregnancy
may permanently alter the DNA methylation profiles
of CD24+CD61+CD29hi cells. Nevertheless, since the
CD24+CD61+CD29hi cell fraction is composed of multiple
cell types, the observed differences in molecular profiles
might be influenced by changes in the biological compo-
sition of this phenotypically defined population.
The majority of promoters did not show significant DNA
methylation changes across cell type (n = 15,395) or devel-
opmental stage (n = 15,362), in agreement with prior
studies in other organs (Bock et al., 2012; Ziller et al.,
2013). However, in both groups we found a select number
of interesting genes that showed altered promoter
DNA methylation patterns. For instance, 107 and 48 loci
displayed increased and decreased DNA methylation
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Figure 2. Changes in Gene Expression Patterns in the Mammary Epithelium Specific to Cell Type, Age, and Reproductive Stage
(A) Unsupervised hierarchical clustering of mammary epithelial gene expression profiles based on all expressed genes.
(B) 2D projection of the gene expression data onto the first two principal components. Cell types and reproductive stages are indicated by
colors and shapes, respectively.
(C) Top: correlation plot of each cell type in two different developmental stages using the top 10% differential expressed genes. Bottom:
correlation plot of cell types within each developmental stage using the top 10% differential expressed genes. See also Table S4.
(D) Heatmaps depicting genes differentially expressed among cell types in 3- to 9-week-old virgin, pregnant, and retired breeder mice.
Green rectangles highlight cell-type-specific genes, with prominent functional categories indicated. 61+hi (red), 61+lo (green), and 61lo
(blue) indicate CD24+CD61+CD29hi, CD24+CD61+CD29lo, and CD24+CD61CD29lo, respectively. See also Table S2.
(E) Heatmaps depicting genes differentially expressed among cell types in 3- to 9-week-old virgin, 24-week-old virgin, and retired breeder
mice. Green rectangles highlight cell-type-specific genes, with prominent functional categories indicated. 61+hi (red), 61+lo (green), and
61lo (blue) indicate CD24+CD61+CD29hi, CD24+CD61+CD29lo, and CD24+CD61CD29lo, respectively. See also Table S3.
(F) Heatmap depicting clustering of the samples based on the mRNA levels of TFs differentially expressed between cell types and
reproductive stages. TFs with known roles in mammary gland development are highlighted in red.
(G) Heatmap depicting mRNA levels of selected TFs differentially expressed in CD24+CD61+CD29hi cells according to age and reproductive
stage.
(H and I) qRT-PCR validation of the expression of selected TFs that were highly expressed in CD24+CD61+CD29hi cells regardless of repro-
ductive status (H) or at a specific stage (I). 61+hi (red), 61+lo (green), and 61lo (blue) indicate CD24+CD61+CD29hi, CD24+CD61+CD29lo, and
CD24+CD61CD29lo, respectively.
See also Figure S2.
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levels, respectively, in CD24+CD61+CD29lo cells, and
these remained at approximately the same levels in
CD24+CD61CD29lo cells (Figures 3D and S2D; Table S6).
Genes that were hypermethylated in CD24+CD61+CD29lo
and CD24+CD61CD29lo cells included stem-cell-related
genes (e.g., Angptl2), whereas many hypomethylated genes
were related to epithelial cell differentiation (e.g., Elf5 and
Cldn4). Similarly, 78 genes gained and 56 genes lost pro-
moter DNA methylation in all cells from retired breeder
mice compared with those from virgin and pregnant
Figure 3. Changes in DNA Methylation Patterns in the Mammary Epithelium Specific to Cell Type, Age, and Reproductive Stage
(A) Clustering of different cell types from skin, blood, and mammary gland using Ward’s method of Pearson correlations between individual
CpGs that were present in each pairwise comparison with coverage of five or more reads.
(B and C) Hierarchical clustering based on the mean DNA methylation in promoter (B) and enhancer (C) regions.
(D) Changes in promoter DNA methylation between cell types (left) and reproductive stages (right) are separated into classes of genes that
show no change, increase, or decrease in DNA methylation. Selected genes with known functions in stem cells or mammary gland
development are listed.
(E) Top: correlation plot of each cell type in two different developmental stages using the top 10% differential methylated genes. Bottom:
correlation plot of cell types within each developmental stage using the top 10% differential methylated genes. 61+hi (red), 61+lo (green),
and 61lo (blue) indicate CD24+CD61+CD29hi, CD24+CD61+CD29lo, and CD24+CD61CD29lo, respectively.
(F) Comparison of promoter and enhancer DNA methylation of each cell type at different age and reproductive stages. For each gene, the
initial 3w virgin methylation level was set to 0, and the final retired level was set to 1. At each intermediate stage, the methylation level for
that stage was normalized as a proportion of the absolute change between the initial 3-week-old virgin and the final retired methylation
level. The boxplot summarizes the relative methylation values for each gene. The bar shows the median value and the box shows the inner
quartile range, with whiskers (which extend beyond the plot edges) showing the range of data values.
See also Figures S2 and S3 and Tables S4, S6, and S7.
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animals (Figure 3D). Several of these genes have known
oncogenic (e.g., Hoxb3) (Li et al., 2012) or tumor-suppres-
sive (e.g., Ctcfl) (Tiffen et al., 2013) functions in breast
cancer. The expression and promoter DNA methylation
of class 2 and 3 genes in different cell types and reproduc-
tive stages clearly showed a reverse correlation, suggesting
that changes in promoter DNA methylation play a role
in regulating gene expression (Figure S2E). We performed
a functional classification of genes in each class of Fig-
ure 3D, but the relatively low number of genes did not
reveal enrichment for significant biological functions.
However, there was some overlap in the functional terms
characterizing differentially expressed and differentially
methylated genes, including ‘‘tissue development’’ and
‘‘DNA binding.’’
Next, we analyzed the relative differences in DNA
methylation between cell types at different stages as well
as stage-specific differences within the same cell type. Un-
like expression, for which cells developed specific tran-
scriptional identities with cell-type maturation, the DNA
methylation landscape appeared to vary most with the
progression of reproductive stages, with a gradual decrease
in correlation between DNA methylation states going
from virgin to pregnant to retired breeder mice (Figure 3E;
Table S4).
To further explore pregnancy-induced and persistent
methylation changes, we compared the DNA methylation
values for all stages relative to the initial (week 3) and final
(retired breeder) stages (Figure 3F). CD24+CD61+CD29hi
showed a gradual trend toward retired breeder values
from puberty through aging and pregnancy in both
promoter and enhancer methylation, and these values
were maintained through late pregnancy and postpreg-
nancy stages. These results provided further evidence
that aging and pregnancy are associated with persistent
DNA methylation changes in CD24+CD61+CD29hi and
CD24+CD61+CD29lo cells, whereas the DNA methylation
patterns of CD24+CD61CD29lo cells are stable. Despite
the relatively similar trend in the degree of DNA methyl-
ation in old virgin and pregnant mice, the actual identities
of the genes that showed these changes were different:
lowly expressed geneswere preferentially hypermethylated
due to age, but not to pregnancy. This is similar to previous
findings in blood, which showed that silent genes were
targets for aberrant age-related silencing (Beerman et al.,
2013).
To further investigate core signatures characterizing
pregnancy-induced and persistent methylation changes,
we analyzed the top 10% of genes that had differential
DNA methylation in the promoters or enhancers between
3-week-old virgin and retired breeders, and remained be-
tween 50% and 150% in the pregnant mice (Figure S2E).
Several genes with pregnancy-induced and persistent
DNAmethylation changes have known roles in mammary
gland development (e.g., Wnt3) or breast tumorigenesis
(e.g., Hs3st2 and Trim29) (Table S7).
We also analyzed the gene expression profiles of mam-
mary glands from mice treated with AzaC or VPA. Treat-
ment with these agents induced more pronounced effects
on gene expression in pregnant mice, potentially due to
the higher fraction of proliferative cells that were more
responsive to epigenetic drugs (Figure S3A). Interestingly,
almost all genes with a change in expression were altered
in the same way by both AzaC and VPA. Consistent with
decreased cell proliferation, both AzaC and VPA treatment
decreased cyclin D1 (Ccnd1) expression. Additionally,
most genes induced by these treatments did not show
cell-type or developmental-stage-specific expression or
methylation changes, with the exception of a handful of
AzaC-induced genes (e.g., Cldn4) that were differentially
expressed and methylated between CD24+CD61+CD29hi
and CD24+CD61CD29lo cells (Figure S3B).
Integrated View of Epigenetic and Gene Expression
Patterns
Histone H3 lysine 4 trimethyl (H3K4me3) andH3 lysine 27
(H3K27) methylation is involved in the regulation of
gene expression patterns (Bernstein et al., 2007). To inves-
tigate the relative contribution of these two types of mod-
ifications to cell-type- or developmental-stage-specific
changes in gene expression in the mammary epithelium,
we performed an integrated analysis of our gene expression
and DNA methylation data, and recently published
H3K4me3 and H3K27me3 chromatin immunoprecipita-
tion sequencing (ChIP-seq) data for matching cell popula-
tions (Pal et al., 2013).
Although transcript levels varied between cell types,
most of these changes were not associated with a change
in promoter methylation or chromatin state (Figures 4A
and S4A), suggesting that they play only a minor
role in the transcriptional regulation of most genes
involved in our system. Nonetheless, signs of epigenetic
regulation were evident in a small subset of genes. We
selected the transition from CD24+CD61+CD29hi cells to
CD24+CD61+CD29lo cells in 9-week-old virginmice, which
showed a large range of change in expression, and for
which histone mark data were available. A striking dy-
namic emerged when we examined histone marks in pro-
moters of genes that were the most differentially regulated
(Figure 4A, right). Genes that were downregulated showed
a gain of H3K27me3 enrichment that was also sometimes
punctuated by a loss of H3K4me3. Amore detailed analysis
of genes with the strongest decrease in expression revealed
an increase in H3K27me3 methylation enrichment
(Figures 4B and 4C). Among these were several genes
with known roles in development and differentiation
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Figure 4. Integrated Analysis of Promoter DNA Methylation, Histone Modification, and Gene Expression Patterns
(A) Promoter DNA methylation and gene expression changes, comparing CD24+CD61+CD29hi cells and CD24+CD61+CD29lo cells in 9-week-
old virgin mice. Changes in H3K4me3 and H3K27me3 enrichment are shown for each gene. The color of each point indicates the final
histone state. Shades of yellow represent genes that have no histone marks in the final stage. Points colored with shades of purple had
both histone marks in the final stage, whereas points colored with shades of green or red resolved to only H3K4me3 or H3K27me3 marks,
respectively. The DNA methylation change (shown by the variance on the x axis) is not generally correlated with changes in expression
(shown by the variance on the y axis).
(B and C) Selected set (from A, box) of loci in stem cells (B) or CD24+CD61+CD29lo cells (C) from 8-week-old virgin mice, limited to
H3K27me3 enrichment.
(D) DNA methylation and genome-browser tracks for H3K4me3 and H3K27me3 patterns for Adamts20, a gene that is highly expressed in
stem cells from virgin mice. The transcription start site and first three exons, as well as the genomic locations of all CpGs in the promoter
region, are shown. Lines are drawn from CpGs covered by RRBS to the measured methylation value. Each black bar is a CpG, the blue scale
indicates the level of DNA methylation, and tracks show enrichment for the indicated histone marks. ChIP-seq read counts were normalized
to sample read coverage, and enrichment is shown for CD24+CD61+CD29hi and CD24+CD61+CD29lo samples.
(E) DNA methylation, gene expression, enrichment for H3K4me3 and H3K27me3, and CpG density for the top 50 differentially methylated
genes in CD24+CD61+CD29hi and CD24+CD61+CD29lo. Differentially methylated genes are sorted into two groups: the top group comprises
genes that showed a greater change from the virgin stage to the pregnant state, with smaller changes between the pregnant and retired
states, and the bottom group comprises genes in which the virgin state was more similar to the retired breeder state.
See also Figure S4.
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(e.g., Bmp4 and Tbx1). Interestingly, ADAMTS20, a secreted
metalloproteinase involved in WNT and KIT signaling (Sil-
ver et al., 2008; Zhang et al., 2008), was highly expressed in
CD24+CD61+CD29hi cells from virgin mice but was
silenced and H3K27me3-enriched in CD24+CD61+CD29lo
cells (Figure 4D). The 181 gene promoters that gained
H3K27me3 methylation in CD24+CD61+CD29lo cells but
were not marked in CD24+CD61+CD29hi cells were mostly
enriched in developmental processes and cell migration
(Figure S4B).
We next analyzed associations amongDNAmethylation,
expression, histone marks, and CpG density for the top 50
genes that showed differential DNA methylation in
CD24+CD61+CD29hi and CD24+CD61+CD29lo cells. These
differentially methylated genes were sorted into two
groups: (1) genes that showed a greater change from the vir-
gin state to the pregnant state, with smaller changes be-
tween the pregnant and retired states; and (2) genes in
which the virgin state was more similar to the retired state.
Several genes such as Ar and Lrp1 in CD24+CD61+CD29hi
cells and Capg and Tcrg1 in CD24+CD61+CD29lo cells
showed uniform high expression and H3K4me3 enrich-
ment in all stages, implying essential roles throughout
life (Figure 4E).
To search for transcription networks that may be
affected by changes in DNA methylation and histone
modification patterns, we analyzed the promoter methyl-
ation of TFs that were differentially expressed between
virgin and retired breeder mice. Foxi1 showed the most
dynamic changes in expression and DNA methylation
among both cell types and developmental stages, with
the highest expression in CD24+CD61+CD29hi cells from
3-week-old virgin mice (Figure S4C). Foxi1 was also one
of the few TFs that were upregulated by AzaC and VPA
treatment in pregnant mice (Figure S3A), further support-
ing its epigenetic regulation. Cldn4, encoding a tight
junction protein, showed the highest expression and
lowest methylation in CD24+CD61CD29lo cells (Fig-
ure 5A). It was also among the most significantly upregu-
lated genes by AzaC treatment (Figure S3), suggesting
that its expression is at least in part regulated by DNA
methylation. Thus, we investigated the expression and
localization of CLDN4 by immunofluorescence in combi-
nation with that of CD61/ITGB3, a cell-surface marker
that is used to identify CD24+CD61+CD29hi and
CD24+CD61+CD29lo cells. In 9-week-old virgin control
mice, CLDN4 was localized between luminal epithelial
cells, whereas CD61 was only seen in the basal layer that
is in contact with the basement membrane (Figure 5B).
However, in AzaC-treatedmice and, evenmore remarkably,
in 9-week-old Dnmt1+/chip mice, the localization of both
CLDN4 and CD61 was altered and they displayed a signif-
icant overlap (Figure 5B), although the frequency of CD61+
cells did not change. These results further support the regu-
lation of Cldn4 expression by DNA methylation.
Key Roles for p27 and TGFb Signaling in Mammary
Epithelial Progenitors
Our molecular profiling demonstrated that pregnancy has
the most pronounced effect on CD24+CD61+CD29hi and
CD24+CD61+CD29lo cells (Figures 2B and 2C). We identi-
fied focal adhesion and the TGFb signaling pathway as be-
ing more highly activated in CD24+CD61+CD29lo cells
from 9-week-old virgin mice compared with mice in other
stages (Figure 6A). In our related studies in human breast,
we also identified the TGFb signaling pathway and p27
(Cdkn1b) as being the most significantly altered by parity
and as key regulators of mammary epithelial progenitor
cell proliferation (Choudhury et al., 2013). To further
investigate the evolutionary conservation of these find-
ings, we analyzed the expression of p27 and members of
the TGFb signaling pathway in our gene expression data.
Expression of p27 was highest in CD24+CD61+CD29hi
and CD24+CD61+CD29lo cells from 9-week-old mice, and
much lower levels were observed in other reproductive
stages and in CD24+CD61CD29lo cells (Figures 6B and
S5). Since the expression of p27 is commonly regulated at
the protein level, we performed immunoblot analysis of
purified cell populations from virgin and retired breeder
mice, which showed higher p27 protein levels in
CD24+CD61+CD29lo cells from 9-week-old virgin mice
(Figure 6C). To analyze the expression of p27 and the local-
ization of p27+ cells in intact mammary tissues, we per-
formed immunofluorescence in combination with CD61.
This analysis showed high expression of p27 in CD61+ cells
in 9-week-old and even 24-week-old virgin mice, whereas
no such cells were detected in retired breeders (Figure 6D
and S5A).
To investigate whether decreased TGFb levels might
influence the frequency of p27+ cells, we performed an
immunofluorescence analysis of p27 and CD61 in mam-
mary glands from virgin Tgfb1+/+ and Tgfb1+/ (Ewan
et al., 2002, 2005) and mammary epithelium-specific
Tgfbr2 knockout (Forrester et al., 2005) mice. We found a
higher frequency of p27+ cells in both Tgfb1+/ and older
(21- to 29-week-old) Tgfbr2/ mice (Figures 6E and 6F),
implying an expansion of the CD24+CD61+CD29lo cell
pool with proliferative capacity due to decreased TGFb
signaling. However, none of these differences reached
statistical significance.
To address the regulation of p27+ progenitors by hor-
monal and TGFb signaling more directly, we established a
mammary gland explant culture model. The use of explant
cultures in which the tissue remains intact has the advan-
tage that the cells remain in their intact microenviron-
ment. Several recent studies have demonstrated that the
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dissociation of the cells and cell culture by itself increases
the progenitor potential of mammary epithelial cells and
may also shift them to amoremyoepithelial lineage (Prater
et al., 2014; Stingl, 2009). We used this explant model to
analyze the frequencies of p27+ and proliferating (Ki67+
or BrdU+) cells after treatment with ovarian hormones
mimicking different phases of the estrus/menstrual cycle
in the presence or absence of a TGFBR kinase inhibitor
(LY2109761). The frequency of p27+ cells was higher in
the mammary tissue of 9-week-old virgins compared with
retired breeders, was inversely correlated with that of
Ki67+ and BrdU+ cells, and was decreased after TGFBR ki-
nase inhibitor (TGFBRi) treatment (Figures 6G–6I and
S5B). In tissues from retired breeders TGFBRi and hormonal
treatment did not induce any significant changes, due to
the very low basal levels of p27+ and BrdU+ cells. These re-
sults suggest a high degree of conservation in the regula-
tion of hormone-responsive mammary epithelial progeni-
tors by parity between mice and humans (Choudhury
et al., 2013), and key roles for p27 and TGFb signaling in
this process.
DISCUSSION
Our comprehensive gene expression andDNAmethylation
profiles covering multiple cell types in normal mammary
gland from mice of different ages and reproductive stages
provide a rich resource for future investigations of the
way in which age- and pregnancy-induced DNA methyl-
ation alters CD24+CD61+CD29hi and CD24+CD61+CD29lo
cells, potentially restricting their hormone responsiveness
and proliferative capacity, which may contribute to the
decreased susceptibility of parousmice tomammary tumor-
igenesis (Russo et al., 2005, 2006a, 2006b). Through our an-
alyses, we found that pregnancy has the most pronounced
effect on CD24+CD61+CD29hi and CD24+CD61+CD29lo
cells, andmany of the differences relate to the downregula-
tion of genes and pathways that are important for stem cell
function, including Hedgehog and TGFb signaling.
The expression profiles of the three distinct cell popula-
tions show a high correlation in 3-week-old virgin mice,
which represents the prepubertal immature mammary
gland, but become very distinct with puberty and even
more so during pregnancy, whereas cells from retired
breeders resemble those from mice in prepregnant virgin
states. These results suggest that the transcriptome and
the phenotype of mammary epithelial cells are mostly
influenced by reproductive hormones (Asselin-Labat
et al., 2010). We identified several TFs with expression
restricted to CD24+CD61+CD29hi cells, many of which
belong to the Id, Snai, and Foxo gene families. All of these
gene families are targets of TGFb signaling and have known
roles in stem cells (Eijkelenboom and Burgering, 2013; Ru-
zinova and Benezra, 2003). Some of these TFs were ex-
pressed in CD24+CD61+CD29hi cells regardless of age or
reproductive stage (e.g., Id4 and Snai2), implying that
they play key roles in stem cell function, whereas others
were only present in prepubertal virgin (e.g., Snai1) or
retired breeder (e.g., Foxd3) mice, potentially reflecting
stage-specific function.
In contrast to the significant cell-type- and reproductive-
stage-specific differences in gene expression profiles, the
DNA methylation and histone modification (H3K27me3)
patterns showed much less pronounced changes. For the
majority of differentially expressed genes, alterations in
mRNA levels were not associated with changes in DNA
methylation or enrichment for theH3K27me3mark. These
findings are consistent with results of studies that investi-
gated the DNA methylation profiles of a wide array of cell
types in both mice and humans (Bock et al., 2012; Ziller
et al., 2013), and with the relatively minor effects of Ezh2
deletion on mammary epithelial cell differentiation (Mi-
chalak et al., 2013; Pal et al., 2013). A few TFs (e.g., Trp73
and Foxi1) displayed both differential DNA methylation
and expression among cell types or across stages, and
Foxi1 expression was also induced by AzaC and VPA treat-
ment. As none of these TFs have been analyzed in the
mammary gland, the physiologic relevance of their expres-
sion and epigenetic patterns is still unclear. However, their
function in other organs suggests potential roles in mam-
mary epithelial stem or progenitor cells.
CD24+CD61+CD29hi cells formed the most distinct
category in both the gene expression and DNA methyl-
ation profiles. Whereas expression profiles separated
CD24+CD61+CD29hi cells from all ages and reproductive
stages into a unique group, clustering based on DNA
methylation levels suggested that age and pregnancy
Figure 5. CLDN4 Expression and DNA Methylation Patterns in Mammary Epithelial Cells
(A) Degree of Cldn4 DNA methylation and gene expression. The transcription start site and gene (single exon), as well as all CpGs along the
genomic coordinates, are shown. Lines are drawn from CpGs covered by RRBS to a column showing the methylation state of that CpG in each
sample. Sample methylation averages and normalized expression values are shown to the right of the image.
(B) Top: representative multicolor immunofluorescence analysis of CLDN4 (red) and CD61 (green) expression in mammary glands from the
indicated treatment groups. Nuclei are visualized by DAPI (blue) stain. Scale bar, 25 mm. Bottom: RGB spectra demonstrating the overlap
between CD61 and CLDN4.
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induce unique changes in the DNAmethylation profiles of
CD24+CD61+CD29hi cells, which then may alter their self-
renewal and differentiation capacity. As proliferative (i.e.,
stem and progenitor) cells are thought to be the cellular tar-
gets of neoplastic transformation, investigating these DNA
methylation changes in further detail may reveal markers
relevant to breast cancer risk. Related to this, our finding
that p27 and TGFb signaling show the most significant
differential expression and activity between CD24+
CD61+CD29lo cells from 9-week-old virgin and retired
breeder mice correlates with our recent results describing
the association of these genes with breast cancer risk in
women (Choudhury et al., 2013).
In summary, our data support the hypothesis that preg-
nancy induces permanent changes in CD24+CD61+CD29hi
and CD24+CD61+CD29lo cells that are relevant to breast
cancer risk, and imply that depletion of these cells may
be a feasible cancer prevention strategy. Since studies in
mice appear to reproduce our findings in women, they
may provide a physiologically relevant preclinical model
in which to test the feasibility of such a strategy.
EXPERIMENTAL PROCEDURES
Mice
We purchased 3-, 9-, and 24-week-old virgin; D10, D16, and D19
timed pregnant; and retired breeder C57BL6 female mice from
Charles River Laboratories (Wilmington, MA) and The Jackson
Laboratory (Bar Harbor, ME). All animal experiments were con-
ducted by trained personnel and followed protocols approved by
the Dana-Farber Cancer Institute and Harvard Medical School An-
imal Care and Use Committees. For inhibitor treatment experi-
ments, 125–250 ng/g of AzaC and 100–300 mg/g (weight of mouse)
of VPAwere dissolved in 150–300 ml PBS and delivered by intraper-
itoneal injections (Figure S1A). Control mice received PBS only.
Dnmt1+/chip mice (Gaudet et al., 2003) were bred and maintained
in Boston Children’s Hospital according to procedures approved
by the IACUC.
Histology, Immunohistochemistry, and
Immunofluorescence Analyses
Histology, immunohistochemical staining, and multicolor immu-
nofluorescence analysis for BrdU, Ki67, p27, CD61, and CLDN4
(Life Technologies) were performed as previously described
(Choudhury et al., 2013). Whole-mount mouse mammary glands
were fixed in Carnoy’s solution and stained with carmine. Samples
were imaged on a Nikon Ti/E inverted microscope using Nikon El-
ements software.
For further details regarding the materials and methods used in
this work, see Supplemental Experimental Procedures.
ACCESSION NUMBERS
The raw data files and details regarding the methods reported in
this work have been deposited in the Gene Expression Omnibus
under accession number GSE54150.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, six figures, and seven tables and can be found with
this article online at http://dx.doi.org/10.1016/j.stemcr.2014.12.
009.
Figure 6. Cell-, Age-, and Reproductive-Stage-Specific Expression of p27 and Its Regulation by TGFb Signaling
(A) Signaling pathways significantly enriched in genes differentially expressed in CD24+CD61+CD29lo cells between 9-week-old virgin and
retired breeder mice.
(B) Heatmap depicting the expression of genes related to TGFb signaling in CD24+CD61+CD29hi and CD24+CD61+CD29lo from 9- and 24-
week-old virgin and retired breeder mice.
(C) Immunoblot analysis of p27 protein levels in CD24+CD61+CD29lo and CD24+CD61CD29lo cells from 9-week-old virgin and retired
breeder mice.
(D) Multicolor immunofluorescence analysis of p27 (red) and CD61 (green) expression in mammary glands from 9-week-old virgin and
retired breeder mice. Nuclei are visualized by DAPI (blue) stain. White arrows indicate p27+CD61+ progenitors in mammary glands of 9-
week-old virgin mice. Scale bar, 25 mm.
(E) Left: multicolor immunofluorescence analysis of p27 (red) and CD61 (green) expression in mammary glands from Tgfb1+/+ and Tgfb1+/
mice. Nuclei are visualized by DAPI (blue) stain. Right: graph depicting quantification of the frequency of p27+ cells. Error bars represent
median ± SEM.
(F) Left: multicolor immunofluorescence analysis of p27 (red) and CD61 (green) expression in mammary glands from Tgfbr2+/+ and
Tgfbr2/ mice. Nuclei are visualized by DAPI (blue) stain. Right: graph depicting quantification of the frequency of p27+ cells. Error bars
represent median ± SEM.
(G) Multicolor immunofluorescence analysis of p27 and BrdU expression in tissue slices from mammary glands of 9-week-old virgin and
retired breeder mice untreated or treated with TGFBRi and ovarian hormones mimicking the luteal phase in mouse (M) and human (H).
Nuclei are visualized by DAPI (blue) stain. Scale bar, 25 mm.
(H and I) Frequency of p27+ (H) and BrdU+ (I) cells in tissue slices from three to five independent cases treated with TGFb receptor inhibitor
(TGFBRi) and ovarian hormones mimicking the luteal phase in mouse (M) and human (H). Asterisks (*) indicate significant difference (p <
0.05, multiple t tests). Error bars represent median ± SEM.
See also Figure S5.
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